The Lupus Nephritis market is anticipated to show positive growth owing to factors such as increasing prevalence, strong pipeline activity, and the presence of multiple Large-Cap Pharma players. LAS
IgA Nephropathy market is expected to experience a growth boost mainly attributed to increased prevalence, anticipated launch of novel therapies, and also the key pharmaceuticals like Novartis